Sodium phenylpyruvate

CAS No. 114-76-1

Sodium phenylpyruvate( Phenylpyruvic acid sodium salt )

Catalog No. M19939 CAS No. 114-76-1

Phenylpyruvic acid is a substrate for phenylpyruvate decarboxylase and phenylpyruvate tautomerase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 28 In Stock
100MG 41 In Stock
200MG Get Quote In Stock
500MG 105 In Stock
1G 151 In Stock

Biological Information

  • Product Name
    Sodium phenylpyruvate
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenylpyruvic acid is a substrate for phenylpyruvate decarboxylase and phenylpyruvate tautomerase.
  • Description
    Phenylpyruvic acid is a substrate for phenylpyruvate decarboxylase and phenylpyruvate tautomerase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Phenylpyruvic acid sodium salt
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114-76-1
  • Formula Weight
    186.14
  • Molecular Formula
    C9H7NaO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    [Na+].[O-]C(=O)C(=O)Cc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shoemaker JD et al. Automated screening of urine samples for carbohydrates organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.
molnova catalog
related products
  • α-Factor Mating Pher...

    The alpha factor pheromone arrests yeast in the G1 phase of their cell cycle. Alpha Factor Mating Pheromone induces the expression of mating genes, changes in nuclear architecture, and polarzes growth toward the mating partner.

  • IM156

    IM156 is an orally bioavailable mitochondrial oxidative phosphorylation (OxPhos) inhibitor, with potential antineoplastic activity.

  • GRGDSP acetate(91037...

    GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.